 | This article has multiple issues. Please help improve it or discuss these issues on the talk page . (Learn how and when to remove these template messages)
|
Benjamin P. Sachs is a physician with health care management experience at the Harvard Medical School hospitals and the Tulane University Medical Center.
Sachs was born in London, the son of Holocaust survivors. [1] He graduated from St. Mary's Hospital Medical School in London. He received a degree in Public Health from the University of Toronto and completed a residency in obstetrics and gynecology and a fellowship in Maternal-Fetal Medicine at the Brigham & Women's Hospital in Boston.
In 1980, Sachs was a visiting scientist at the Centers for Disease Control in Atlanta. In 1987 he completed the Program for Management Development at the Harvard Business School.
Sach's background is in clinical medicine, public health - health policy and finance - business administration with extensive executive experience in physician and hospital management.
In 1978, Sachs started work at the Harvard Medical School. He would eventually serve as chairman of the OB/GYN Department at Beth Israel Deaconess Medical Center (BIDMC) and the Harvard Medical School. Sachs was also appointed as the Harold H. Rosenfield Professor at Harvard Medical School and the Harvard School of Public Health (1997-2007)
Sachs and Major Peter Nielsen, MD, led a team to transfer the concept of crew resource management to obstetrical care. Funded by the U.S. Department of Defense and the Harvard Risk Management Foundation, this was the first major research effort to evaluate team training in healthcare. This crew resource management program formed the basis for TeamSTEPPS, the Agency for Healthcare Research and Quality's national program. TeamSTEPPS is used in hospital Ob/Gyn, surgical, emergency medicine and ICU care departments.
Sachs helped create a research team led by Dr. Ananth Karumanchi that discovered the probable cause of preeclampsia. [2] The team's research was published in the Journal of the American Medical Association, the New England Journal of Medicine, the Journal of Clinical Investigation, Nature Medicine, and was described in The New Yorker.
Sachs was also served as president of the Beth Israel-Deaconess Physician Organization.
Sachs joined Tulane Medical School in November 2007. [2] The university had suffered $900 million in damage from Hurricane Katrina and lost a third of the medical school faculty. [1] [7] Sachs' objectives were to help Tulane recover and to fundamentally redesign the medical school and the New Orleans healthcare system. Sachs created a network of 68 clinics in the New Orleans area that by 2010 was treating approximately 200,000 people per year. [1]
During Sachs' tenure, Tulane Medical School hired more leaders and increased the entrance exam scores of its students. It received the 2010 Association of American Medical Colleges Spencer Foreman Award for outstanding community service. [1]
Sachs served at Tulane for six years as Senior Vice President, dean of the Medical School and the James R. Doty Distinguished Professor and Chair. Sachs retired from Tulane in 2014. [1]
In June 2014, Sachs was appointed the interim dean of the new School of Medicine being developed by the University of the Virgin Islands in St. Croix. [3] Sachs is helping UVISOM become the first English-speaking medical school Caribbean region that is Liaison Committee on Medical Education (LCME) accredited.
Tulane University, officially the Tulane University of Louisiana, is a private research university in New Orleans, Louisiana. Founded as the Medical College of Louisiana in 1834 by seven young medical doctors, it was turned into a comprehensive public university as the University of Louisiana by the state legislature in 1847. The institution became private under the endowments of Paul Tulane and Josephine Louise Newcomb in 1884 and 1887. The Tulane University Law School and Tulane University Medical School are, respectively, the 12th oldest law school and 15th oldest medical school in the United States.
Eclampsia is the onset of seizures (convulsions) in a woman with pre-eclampsia. Pre-eclampsia is a hypertensive disorder of pregnancy that presents with three main features: new onset of high blood pressure, large amounts of protein in the urine or other organ dysfunction, and edema. If left untreated, pre-eclampsia can result in long-term consequences for the mother, namely increased risk of cardiovascular diseases and associated complications. In more severe cases, it may be fatal for both the mother and the fetus. The diagnostic criteria for pre-eclampsia is high blood pressure occurring after 20 weeks gestation or during the second half of pregnancy. Most often it occurs during the 3rd trimester of pregnancy and may occur before, during, or after delivery. The seizures are of the tonic–clonic type and typically last about a minute. Following the seizure, there is either a period of confusion or coma. Other complications include aspiration pneumonia, cerebral hemorrhage, kidney failure, pulmonary edema, HELLP syndrome, coagulopathy, placental abruption and cardiac arrest.
Obstetric ultrasonography, or prenatal ultrasound, is the use of medical ultrasonography in pregnancy, in which sound waves are used to create real-time visual images of the developing embryo or fetus in the uterus (womb). The procedure is a standard part of prenatal care in many countries, as it can provide a variety of information about the health of the mother, the timing and progress of the pregnancy, and the health and development of the embryo or fetus.
Fetal distress, also known as non-reassuring fetal status, is a condition during pregnancy or labor in which the fetus shows signs of inadequate oxygenation. Due to its imprecision, the term "fetal distress" has fallen out of use in American obstetrics. The term "non-reassuring fetal status" has largely replaced it. It is characterized by changes in fetal movement, growth, heart rate, and presence of meconium stained fluid.
The Tulane University School of Medicine is located in New Orleans, Louisiana, United States and is a part of Tulane University. The school is located in the Medical District of the New Orleans Central Business District.
The Association of American Medical Colleges (AAMC) is a nonprofit organization based in Washington, D.C. that was established in 1876. It represents medical schools, teaching hospitals, and academic and scientific societies, while providing services to its member institutions that include data from medical, education, and health studies, as well as consulting. The AAMC administers the Medical College Admission Test and operates the American Medical College Application Service and the Electronic Residency Application Service. Along with the American Medical Association (AMA), the AAMC co-sponsors the Liaison Committee on Medical Education (LCME), the accrediting body for all U.S. MD-granting medical education programs.
HELLP syndrome is a complication of pregnancy; the acronym stands for hemolysis, elevated liver enzymes, and low platelet count. It usually begins during the last three months of pregnancy or shortly after childbirth. Symptoms may include feeling tired, retaining fluid, headache, nausea, upper right abdominal pain, blurry vision, nosebleeds, and seizures. Complications may include disseminated intravascular coagulation, placental abruption, and kidney failure.
W. David Hager is an American physician with a medical board certification in obstetrics and gynecology. In the fall of 2002, Hager, a leading conservative Christian voice on women's health and sexuality, was appointed to the Advisory Committee for Reproductive Health Drugs in the Food and Drug Administration (FDA) by U.S. President George W. Bush.
William Griffith McBride was an Australian obstetrician. He published a letter on the teratogenicity of thalidomide following the findings of a midwife named Pat Sparrow, which resulted in the reduction of the number of drugs prescribed during pregnancy. Later in his life, McBride was found guilty of separate counts of medical malpractice and scientific fraud for falsifying data in a paper that claimed that the drug Debendox was also responsible for birth defects.
Bloody show or show is the passage of a small amount of blood or blood-tinged mucus through the vagina near the end of pregnancy. It is caused by thinning and dilation of the cervix, leading to detachment of the cervical mucus plug that seals the cervix during pregnancy and tearing of small cervical blood vessels, and is one of the signs that labor may be imminent. The bloody show may be expelled from the vagina in pieces or altogether and often appears as a jelly-like piece of mucus stained with blood. Although the bloody show may be alarming at first, it is not a concern of patient health after 37 weeks gestation.
Hysterotomy abortion is a surgical procedure that removes an intact fetus from the uterus in a process similar to a cesarean section. The procedure is generally indicated after another method of termination has failed, or when such a procedure would be medically inadvisable, such as in the case of placenta accreta.
Soluble fms-like tyrosine kinase-1 is a tyrosine kinase protein with antiangiogenic properties. A non-membrane associated splice variant of VEGF receptor 1 (Flt-1), sFlt-1 binds the angiogenic factors VEGF and PlGF, reducing blood vessel growth through reduction of free VEGF and PlGF concentrations. In humans, sFlt-1 is important in the regulation of blood vessel formation in diverse tissues, including the kidneys, cornea, and uterus. Abnormally high levels of sFlt-1 have been implicated in the pathogenesis of preeclampsia.
Tokophobia is a significant fear of childbirth. It is a common reason why some women request an elective cesarean section. The fear often includes fear of injury to the baby, genital tract, or death. Treatment may occur via counselling.
Stuart Campbell DSc FRCPEd FRCOG FACOG, was born in Glasgow, Scotland, and graduated from the medical school of Glasgow University. During his training he worked with Ian Donald, who had published some of the first papers on the use of ultrasound in obstetrics.
John M. Barry is an American author and historian who has written books on the Great Mississippi Flood of 1927, the influenza pandemic of 1918, and the development of the modern form of the ideas of separation of church and state and individual liberty. He is a professor at the Tulane University School of Public Health and Tropical Medicine and Distinguished Scholar at Tulane's Bywater Institute.
David A. Savitz is a professor of Community Health in the Epidemiology Section of the Program in Public Health, Vice President for Research, and Professor of Obstetrics and Gynecology, at The Alpert Medical School of Brown University, and Associate Director for Perinatal Research in The Department of Obstetrics and Gynecology at Women & Infants Hospital, both in Providence, Rhode Island. Savitz is the author of Interpreting epidemiologic evidence: strategies for study design and analysis (ISBN 0-19-510840-X) and more than 275 peer-reviewed articles. He was elected to the Institute of Medicine in 2007.
Michael L. Brodman is an American gynecologist and obstetrician and currently the Ellen and Howard C. Katz Professor and Chairman of the Department of Obstetrics, Gynecology and Reproductive Science at Mount Sinai Hospital, Mount Sinai Health System, and Icahn School of Medicine at Mount Sinai in New York City. He is recognized internationally as a pioneer in the field of urogynecology.
Scott B. Ransom has worked across the healthcare ecosystem as a physician, researcher, teacher, author, executive, strategy consultant and investor.
Anna Cherrie Epps was an American microbiologist known for her immunology research as well as her efforts to promote the advancement of minorities within the sciences, specifically medicine.
Asif Ahmed FRSB is a British-Indian vascular scientist, whose research focuses on reducing the risk of mortality and morbidity in pregnancy. He is the founder and former Pro-Vice-Chancellor and Executive Dean of Aston Medical School, Birmingham, and established the Aston Medical Research Institute, a university-wide multidisciplinary translational research entity at Aston University.
| International | |
|---|---|
| National | |
| Other | |
